Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

被引：0
|
作者：
Katerina Chatzidionysiou
Elisabeth Lie
Evgeny Nasonov
Galina Lukina
Merete Lund Hetland
Ulrik Tarp
Ioan Ancuta
Karel Pavelka
Dan C. Nordström
Cem Gabay
Helene Canhão
Matija Tomsic
Piet L. C. M. van Riel
Juan Gomez-Reino
Tore K. Kvien
Ronald F. van Vollenhoven
机构：
[1] Karolinska Universitetssjukhustet,Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00
[2] Diakonhjemmet Hospital,Department of Rheumatology
[3] ARBITER,DANBIO, Department of Rheumatology
[4] Institute of Rheumatology,Department of Rheumatology
[5] Copenhagen University Hospital at Glostrup,Rheumatic Diseases Portuguese Register
[6] Aarhus University Hospital,undefined
[7] Cantacuzino Hospital,undefined
[8] Charles University,undefined
[9] ROB-FIN Helsinki University Central Hospital,undefined
[10] SCQM registry,undefined
[11] University Hospital of Geneva,undefined
[12] Rheumatology Research Unit,undefined
[13] Instituto de Medicina Molecular,undefined
[14] University Medical Center,undefined
[15] Radboud University Nijmegen Medical Centre,undefined
[16] Hospital Clinico Universitet De Santiago,undefined
来源：
Arthritis Research & Therapy | / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effectiveness of TNF inhibitor treatment with various methotrexate doses in patients with rheumatoid arthritis: results from clinical practice
    Manders, Sofie H. M.
    Kievit, Wietske
    Adang, Eddy
    Jansen, Tim J.
    Stolk, Jan N.
    Visser, Henk
    Schilder, Annemarie M.
    Vonkeman, Harald E.
    van de Laar, Mart A. F. J.
    van Riel, Piet L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03)
  • [22] Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
    Salmon, J. H.
    Cacoub, P.
    Combe, B.
    Sibilia, J.
    Pallot-Prades, B.
    Fain, O.
    Cantagrel, A.
    Dougados, M.
    Andres, E.
    Meyer, O.
    Carli, P.
    Pertuiset, E.
    Pane, I.
    Maurier, F.
    Ravaud, P.
    Mariette, X.
    Gottenberg, J. E.
    RMD OPEN, 2015, 1 (01):
  • [23] Two Year Data on Quality of Life, Pain and Mobility Scores After Rituximab Treatment in the Preclinical Phase of Rheumatoid Arthritis
    Frazzei, Giulia
    Cramer, Sophie
    Landewe, Robert
    Maijer, Karen
    Gerlag, Danielle
    Tak, Paul
    De Vries, Niek
    van Baarsen, Lisa
    Van Vollenhoven, Ronald
    Tas, Sander
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4374 - 4375
  • [24] Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry
    Harrold, Leslie R.
    Reed, George W.
    Shewade, Ashwini
    Magner, Robert
    Saunders, Katherine C.
    John, Ani
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1090 - 1098
  • [25] Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: Data from the international COMORA cohort
    Hmamouchi, Ihsane
    Winthrop, Kevin
    Launay, Odile
    Dougados, Maxime
    VACCINE, 2015, 33 (12) : 1446 - 1452
  • [26] Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
    Jyssum, Ingrid
    Kared, Hassen
    Tran, Trung T.
    Tveter, Anne T.
    Provan, Sella A.
    Sexton, Joseph
    Jorgensen, Kristin K.
    Jahnsen, Jorgen
    Kro, Grete B.
    Warren, David J.
    Vaage, Eline B.
    Kvien, Tore K.
    Nissen-Meyer, Lise-Sofie H.
    Anderson, Ane Marie
    Grodeland, Gunnveig
    Haavardsholm, Espen A.
    Vaage, John Torgils
    Mjaaland, Siri
    Syversen, Silje Watterdal
    Lund-Johansen, Fridtjof
    Munthe, Ludvig A.
    Goll, Guro Lovik
    LANCET RHEUMATOLOGY, 2022, 4 (03): : E177 - E187
  • [27] Effectiveness, Tolerability, and Safety of Subcutaneous Methotrexate in Early Rheumatoid Arthritis: Clinical Data from the St. Gallen Cohort
    Mueller, Ruediger
    von Kempis, Johannes
    Schiff, Michael H.
    Haile, Sarah
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1030 - S1030
  • [28] EFFECTIVENESS, TOLERABILITY, AND SAFETY OF SUBCUTANEOUS METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS: CLINICAL DATA FROM THE ST. GALLEN COHORT
    Mueller, R.
    Schiff, M. H.
    Haile, S. R.
    Von Kempis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 227 - 227
  • [29] Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration
    Gehringer, Celina K.
    Martin, Glen P.
    Hyrich, Kimme L.
    Verstappen, Suzanne M. M.
    Sexton, Joseph
    Kristianslund, Eirik K.
    Provan, Sella A.
    Kvien, Tore K.
    Sergeant, Jamie C.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 166
  • [30] Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort
    Sepriano, Alexandre
    Ramiro, Sofia
    FitzGerald, Oliver
    Ostergaard, Mikkel
    Homik, Joanne
    van der Heijde, Desiree
    Elkayam, Ori
    Thorne, J. Carter
    Larche, Maggie J.
    Ferraccioli, Gianfranco
    Backhaus, Marina
    Burmester, Gerd R.
    Boire, Gilles
    Combe, Bernard
    Schaeverbeke, Thierry
    Saraux, Alain
    Dougados, Maxime
    Rossini, Maurizio
    Govoni, Marcello
    Sinigaglia, Luigi
    Cantagrel, Alain
    Barnabe, Cheryl
    Bingham, Clifton O., III
    Tak, Paul P.
    van Schaardenburg, Dirkjan
    Hammer, Hilde Berner
    Paschke, Joel
    Dadashova, Rana
    Hutchings, Edna
    Landewe, Robert
    Maksymowych, Walter P.
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (06) : 809 - 819
12345